GBLX - GB Sciences, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue3/31/20183/31/20173/31/20163/31/2015
Total Revenue2,510.364---
Cost of Revenue782.727---
Gross Profit1,727.637---
Operating Expenses
Research Development----
Selling General and Administrative19,552.2888,933.1116,958.7697,973.85
Non Recurring----
Others----
Total Operating Expenses20,335.0158,933.1116,958.7697,973.85
Operating Income or Loss-17,824.651-8,933.111-6,958.769-7,973.85
Income from Continuing Operations
Total Other Income/Expenses Net-5,334.574-1,149.992-120.2090.135
Earnings Before Interest and Taxes-17,824.651-8,933.111-6,958.769-7,973.85
Interest Expense-5,176.361-901.134-105.204-105.204
Income Before Tax-23,159.225-10,083.103-7,078.978-7,973.715
Income Tax Expense----
Minority Interest2,882.9977.421-78.603-250.96
Net Income From Continuing Ops-23,159.225-10,083.103-7,078.978-7,973.715
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-22,974.19-9,909.83-6,771.335-7,722.755
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-22,974.19-9,909.83-6,771.335-7,722.755